A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Seagen Inc.
Seagen Inc.
Ohio State University
Endeavor Biomedicines, Inc.
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
University of Nebraska
Novartis
NeoTX Therapeutics Ltd.
HiFiBiO Therapeutics
Seattle Children's Hospital
Actym Therapeutics, Inc.
7 Hills Pharma, LLC
Travera Inc
Incyte Corporation
NuCana plc
Azienda Ospedaliera di Padova
Turnstone Biologics, Corp.
Checkpoint Therapeutics, Inc.
BerGenBio ASA
Sotio Biotech Inc.
Aminex Therapeutics, Inc.
Molecular Templates, Inc.
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
University of California, San Diego
Pfizer
Memorial Sloan Kettering Cancer Center
NGM Biopharmaceuticals, Inc
Massachusetts General Hospital
Rain Oncology Inc
Western Sydney Local Health District
Seagen Inc.
Jules Bordet Institute
Quadriga Biosciences, Inc.
Xencor, Inc.
Incyte Corporation
AbbVie
Infinity Pharmaceuticals, Inc.
MacroGenics
Incyte Corporation
Incyte Corporation
Abramson Cancer Center at Penn Medicine
Shenzhen BinDeBio Ltd.
Swiss Cancer Institute
Novartis
GOG Foundation
Children's Oncology Group
INSYS Therapeutics Inc
University of Chicago
Memorial Sloan Kettering Cancer Center